Skip to main content
Premium Trial:

Request an Annual Quote

Genomic Solutions Amends PerkinElmer Distribution Deal

NEW YORK, Jan. 10—Genomic Solutions has amended its distribution deal with PerkinElmer Life Sciences, the company said Thursday.


Under the new agreement, PerkinElmer will have non-exclusive rights to market and distribute all Genomic Solutions products outside the U.S. and Japan, and assumes non-exclusive distribution rights worldwide for Genomic Solution's Investigator proteomic electrophoresis products. the company's GeneTAC HybStation, and all Cartesian Technologies products.


The two companies have had a comprehensive sales, distribution, and technology alliances since December 1999, when PerkinElmer made an equity investment in the company. After settling a lawsuit regarding that equity stake in spring 2001, the firms expanded that arrangement.

The Scan

Plan Rebuffed

The Associated Press reports China has rejected the World Health Organization's proposal to include the lab-leak theory in the next phase of its investigation into the origins of SARS-CoV-2.

Opossum Change

Researchers from Riken have used CRISPR to edit marsupial genomes, as Technology Review reports.

In the Ice

Cosmos magazine reports that researchers have uncovered more than two dozen ancient viruses in a Tibetan glacier.

Nature Papers Present Method to Uncover Differential RNA Modifications, Neutrophils in Innate Immune Response

In Nature this week: computational approach to identifying differential RNA modifications, and more.